Lixisenatide Doesn’t Affect Cardiovascular Risk in T2DM
Findings among patients with type 2 diabetes and recent acute coronary syndrome
Vitamin D3, Placebo Both Improve Chronic Low Back Pain
No significant between-group difference in decrease in mean pain VAS score, mean change in chronic pain
Evidence Doesn’t Support Monthly Labs With Isotretinoin
Significant changes in values of several laboratory tests, but changes don't meet high-risk criteria
AMA: Case Before Supreme Court Threatens Patient Privacy
Case involves Medical Board obtaining three years of prescribing history for doctor, after single complaint
Anthracyclines More Neurotoxic Than Other Breast CA Regimens
More negative effects on specific cognitive domains, network connections for breast cancer survivors
Safety Concerns Linked to Herbal Medicine Use in Cancer
Concerns include altered pharmacodynamics, direct toxic effects, increased chemosensitivity
Metformin Does Not Boost Glycemic Control in T1DM
Small, but temporary, beneficial effect from metformin was seen early on
November 2015 Briefing – Pharmacy
Here are what the editors at HealthDay consider to be the most important developments in Pharmacy for November 2015. This roundup includes the latest...
Clozapine Benefits Those With Tx-Resistant Schizophrenia
Clozapine already approved for use after other antipsychotics don't work
CDC: Cholesterol Levels Improving But More Work Needed
Adults aged 40 to 59 did not achieve Healthy People 2020 goals in 2011 to 2014
